Comments
Loading...

Hologic Analyst Ratings

HOLXNASDAQ
Logo brought to you by Benzinga Data
$74.97
0.110.15%
At close: Dec 5, 4:00 PM EST
$74.97
N/A
After Hours: 4:49 PM EST
Consensus Rating1
Outperform
Highest Price Target1
$95.00
Lowest Price Target1
$70.00
Consensus Price Target1
$82.33

Hologic Analyst Ratings and Price Targets | NASDAQ:HOLX | Benzinga

Hologic Inc has a consensus price target of $82.33 based on the ratings of 19 analysts. The high is $95 issued by Cowen & Co. on February 2, 2023. The low is $70 issued by UBS on July 31, 2025. The 3 most-recent analyst ratings were released by Morgan Stanley, Mizuho, and Stephens & Co. on November 11, 2025, October 23, 2025, and October 22, 2025, respectively. With an average price target of $76.67 between Morgan Stanley, Mizuho, and Stephens & Co., there's an implied 2.26% upside for Hologic Inc from these most-recent analyst ratings.

Analyst Trends and Forecast

2
2
Jul
1
Aug
2
Sep
1
6
Oct
1
Nov
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
2.8
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Morgan Stanley
Mizuho
Stephens & Co.
JP Morgan
Leerink Partners

1calculated from analyst ratings

Analyst Ratings for Hologic

Get Alert
Nov 11, 2025
1.37%
69
76
Previous
Equal-Weight
Current
Equal-Weight
Oct 23, 2025
4.04%
70
78
Previous
Outperform
Current
Neutral
Oct 22, 2025
—
—
Previous
Outperform
Current
Market Perform
Oct 22, 2025
1.37%
76
78
Previous
Overweight
Current
Equal-Weight
Oct 22, 2025
4.04%
78
Previous
Overweight
Current
Neutral
Oct 21, 2025
4.04%
70
78
Previous
Market Perform
Current
Market Perform
Oct 21, 2025
—
—
Previous
Neutral
Current
Neutral
Oct 21, 2025
—
—
Previous
Hold
Current
Hold
Oct 7, 2025
4.04%
69
78
Previous
In-Line
Current
Outperform
Sep 19, 2025
20.05%
80
90
Previous
Buy
Current
Buy
Sep 18, 2025
4.04%
78
78
Previous
Overweight
Current
Overweight
Aug 6, 2025
16.05%
72
87
Previous
Sector Perform
Current
Outperform
Jul 31, 2025
-7.96%
65
69
Previous
Equal-Weight
Current
Equal-Weight
Jul 31, 2025
-6.63%
65
70
Previous
Neutral
Current
Neutral
Jul 16, 2025
-6.63%
65
70
Previous
Outperform
Current
Outperform
Jul 9, 2025
6.71%
60
80
Previous
Neutral
Current
Buy
Jul 8, 2025
-9.3%
62
68
Previous
In-Line
Current
In-Line
May 28, 2025
—
—
Previous
Hold
Current
Hold
May 13, 2025
-6.63%
70
77
Previous
Overweight
Current
Overweight
May 5, 2025
-13.3%
65
77
Previous
Equal-Weight
Current
Equal-Weight
May 2, 2025
-6.63%
70
75
Previous
Sector Perform
Current
Sector Perform
May 2, 2025
-5.3%
71
90
Previous
Outperform
Current
Outperform
May 2, 2025
-17.3%
62
65
Previous
In-Line
Current
In-Line
May 2, 2025
—
—
Previous
Hold
Current
Hold
Apr 8, 2025
0.04%
75
83
Previous
Sector Perform
Current
Sector Perform
Mar 4, 2025
-6.63%
70
80
Previous
Neutral
Current
Neutral
Feb 6, 2025
20.05%
90
95
Previous
Outperform
Current
Outperform
Feb 6, 2025
13.38%
85
88
Previous
Sector Perform
Current
Sector Perform
Feb 6, 2025
-2.63%
73
76
Previous
In-Line
Current
In-Line
Feb 6, 2025
12.04%
84
84
Previous
Overweight
Current
Overweight
Feb 6, 2025
0.04%
75
80
Previous
Outperform
Current
Market Perform
Feb 6, 2025
—
—
Previous
Hold
Current
Hold
Feb 3, 2025
20.05%
90
90
Previous
Buy
Current
Hold
Jan 13, 2025
9.38%
82
84
Previous
Equal-Weight
Current
Equal-Weight
Jan 13, 2025
20.05%
90
90
Previous
Buy
Current
Buy
Dec 19, 2024
20.05%
90
90
Previous
Buy
Current
Buy
Dec 13, 2024
—
—
Previous
Initiates
Current
Peer Perform
Dec 10, 2024
13.38%
85
Previous
Initiates
Current
Hold
Nov 5, 2024
26.72%
93
95
Previous
Outperform
Current
Outperform
Nov 5, 2024
16.05%
87
90
Previous
Outperform
Current
Outperform
Nov 5, 2024
20.05%
84
90
Previous
Neutral
Current
Neutral
Nov 5, 2024
18.71%
86
89
Previous
Sector Perform
Current
Sector Perform
Nov 5, 2024
25.38%
92
94
Previous
Overweight
Current
Overweight
Oct 15, 2024
20.05%
90
90
Previous
Buy
Current
Buy
Oct 8, 2024
20.05%
90
95
Previous
Outperform
Current
Outperform
Oct 4, 2024
20.05%
85
90
Previous
Outperform
Current
Outperform
Oct 1, 2024
9.38%
78
82
Previous
In-Line
Current
In-Line
Oct 1, 2024
13.38%
85
95
Previous
Buy
Current
Neutral
Sep 17, 2024
20.05%
90
90
Previous
Buy
Current
Buy
Aug 16, 2024
9.38%
82
82
Previous
Sector Perform
Current
Sector Perform
Jul 30, 2024
22.72%
92
92
Previous
Overweight
Current
Overweight
Jul 30, 2024
4.04%
76
78
Previous
In-Line
Current
In-Line
Jul 30, 2024
26.72%
91
95
Previous
Overweight
Current
Overweight
Jul 30, 2024
9.38%
81
82
Previous
Sector Perform
Current
Sector Perform
Jul 30, 2024
20.05%
90
90
Previous
Buy
Current
Buy
Jul 2, 2024
1.37%
76
78
Previous
In-Line
Current
In-Line
Jun 27, 2024
16.05%
87
Previous
Initiates
Current
Overweight
May 9, 2024
26.72%
89
95
Previous
Buy
Current
Buy
May 3, 2024
20.05%
90
90
Previous
Buy
Current
Buy
May 3, 2024
21.38%
85
91
Previous
Overweight
Current
Overweight
Apr 10, 2024
20.05%
90
90
Previous
Buy
Current
Buy
Apr 4, 2024
4.04%
76
78
Previous
In-Line
Current
In-Line
Apr 3, 2024
26.72%
80
95
Previous
Neutral
Current
Buy
Feb 2, 2024
17.38%
85
88
Previous
Outperform
Current
Outperform
Feb 2, 2024
5.38%
78
79
Previous
Neutral
Current
Neutral
Feb 2, 2024
20.05%
83
90
Previous
Buy
Current
Buy
Nov 16, 2023
4.04%
78
91
Previous
Neutral
Current
Neutral
Nov 13, 2023
9.38%
82
86
Previous
Equal-Weight
Current
Equal-Weight
Nov 10, 2023
-3.96%
72
74
Previous
Sector Perform
Current
Sector Perform
Oct 26, 2023
10.71%
83
95
Previous
Buy
Current
Buy
Oct 18, 2023
13.38%
85
95
Previous
Outperform
Current
Outperform
Oct 5, 2023
2.71%
77
81
Previous
Sector Perform
Current
Sector Perform
Aug 1, 2023
26.72%
95
95
Previous
Buy
Current
Buy
Aug 1, 2023
14.71%
86
86
Previous
Equal-Weight
Current
Equal-Weight
Aug 1, 2023
13.38%
85
90
Previous
Neutral
Current
Neutral
Aug 1, 2023
13.38%
85
87
Previous
Sector Perform
Current
Sector Perform
Aug 1, 2023
14.71%
86
94
Previous
Neutral
Current
Neutral
Aug 1, 2023
26.72%
95
100
Previous
Outperform
Current
Outperform
Jul 14, 2023
26.72%
95
Previous
Hold
Current
Buy
Jun 15, 2023
26.72%
95
Previous
Buy
Current
Buy
May 3, 2023
14.71%
81
86
Previous
Current
Equal-Weight
May 2, 2023
16.05%
87
Previous
Current
Sector Perform
May 2, 2023
40.06%
95
105
Previous
Current
Overweight
May 2, 2023
13.38%
80
85
Previous
Current
Equal-Weight
May 2, 2023
33.39%
95
100
Previous
Current
Outperform
May 2, 2023
26.72%
92
95
Previous
Current
Buy
May 2, 2023
20.05%
85
90
Previous
Current
Neutral
Apr 18, 2023
22.72%
90
92
Previous
Current
Buy
Feb 3, 2023
8.04%
74
81
Previous
Current
Equal-Weight
Feb 2, 2023
26.72%
86
95
Previous
Current
Outperform
Feb 2, 2023
26.72%
90
95
Previous
Current
Overweight
Feb 2, 2023
13.38%
75
85
Previous
Current
Neutral
Feb 2, 2023
26.72%
80
95
Previous
Current
Outperform
Feb 2, 2023
24.05%
90
93
Previous
Current
Outperform
Jan 24, 2023
20.05%
77
90
Previous
Current
Buy
Jan 12, 2023
20.05%
85
90
Previous
Current
Outperform
Jan 10, 2023
6.71%
75
80
Previous
Current
Equal-Weight
Jan 6, 2023
13.38%
78
85
Previous
Current
Outperform
Dec 7, 2022
0.04%
75
Previous
Initiates
Current
Sector Perform

FAQ

Q

What is the target price for Hologic (HOLX) stock?

A

The latest price target for Hologic (NASDAQ:HOLX) was reported by Morgan Stanley on November 11, 2025. The analyst firm set a price target for $76.00 expecting HOLX to rise to within 12 months (a possible 1.37% upside). 38 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Hologic (HOLX)?

A

The latest analyst rating for Hologic (NASDAQ:HOLX) was provided by Morgan Stanley, and Hologic maintained their equal-weight rating.

Q

When was the last upgrade for Hologic (HOLX)?

A

The last upgrade for Hologic Inc happened on October 7, 2025 when Evercore ISI Group raised their price target to $78. Evercore ISI Group previously had an in-line for Hologic Inc.

Q

When was the last downgrade for Hologic (HOLX)?

A

The last downgrade for Hologic Inc happened on October 23, 2025 when Mizuho changed their price target from $70 to $78 for Hologic Inc.

Q

When is the next analyst rating going to be posted or updated for Hologic (HOLX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hologic, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hologic was filed on November 11, 2025 so you should expect the next rating to be made available sometime around November 11, 2026.

Q

Is the Analyst Rating Hologic (HOLX) correct?

A

While ratings are subjective and will change, the latest Hologic (HOLX) rating was a maintained with a price target of $69.00 to $76.00. The current price Hologic (HOLX) is trading at is $74.97, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.